PPARA and carcinoma: Since fatty acids and their metabolites are preferential ligands of PPARα, the protein content of this nuclear receptor was evaluated (Figure 1), showing a decrease in carcinoma versus mucosa at all Duke's stages with no significant differences among Duke's stages.